Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 2.130
+0.010 (0.47%)
May 7, 2026, 4:08 PM HKT
Transcenta Holding Market Cap
Transcenta Holding has a market cap or net worth of 958.27 million as of May 7, 2026. Its market cap has increased by 100.90% in one year.
Market Cap
958.27M
Enterprise Value
1.08B
Revenue
8.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.13
Market Cap Chart
Since April 27, 2022, Transcenta Holding's market cap has decreased from 2.75B to 958.27M, a decrease of -65.21%. That is a compound annual growth rate of -23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 958.27M | 0.47% |
| Dec 31, 2025 | 953.77M | 274.36% |
| Dec 31, 2024 | 254.77M | -82.96% |
| Dec 29, 2023 | 1.50B | 14.88% |
| Dec 30, 2022 | 1.30B | -52.74% |
| Apr 27, 2022 | 2.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.64B |
| Kintor Pharmaceutical | 1.44B |
| CANbridge Pharmaceuticals | 1.28B |
| JW (Cayman) Therapeutics Co. | 1.10B |
| Shanghai Bio-heart Biological Technology | 1.07B |
| Brii Biosciences | 996.03M |
| Sunho Biologics | 970.43M |
| Wuhan YZY Biopharma | 891.71M |